MedTrace Logo

Spinal Anesthesia for Outpatient Abdominal Wall Surgery: Comparison of Bupivacaine, 2-chloroprocaine and Prilocaine

NCT02813382 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 101

Last updated 2016-06-28

No results posted yet for this study

Summary

Considering fast-track principles, an ideal spinal anesthetic should have minimal complications and above all fast recovery so reducing in-hospital stay.

Between 1/8/2015 and 1/1/2016, a total of 101 patients attending the surgeon's practice with an umbilical or unilateral inguinal hernia and no contra-indications for surgery were included in this study. Patients were given 10.5mg bupivacaine (B-group), 40mg hyperbaric 2-chloroprocaïne (C-group) or 60mg prilocaïne (P-group), each with added sufentanil (2µg). Motor block was assessed using the Bromage scale. Sensory block was measured by determining the peak level dermatome. Intraoperative hemodynamic parameters were listed. Resolution of sensory and motor block, time to void and home readiness were defined as clinical endpoints.

Conditions

  • Anesthesia, Spinal
  • Ambulatory Surgical Procedures
  • Hernia, Inguinal
  • Hernia, Umbilical

Interventions

DRUG

Bupivacaine

Spinal anesthesia was performed using 10.5mg bupivacaine with added sufentanil (2µg).

DRUG

Prilocaine

Spinal anesthesia was performed using 60mg prilocaïne with added sufentanil (2µg).

DRUG

Chloroprocaine

Spinal anesthesia was performed using 40mg hyperbaric 2-chloroprocaïne with added sufentanil (2µg).

Sponsors & Collaborators

  • AZ St.-Dimpna Geel

    lead OTHER

Principal Investigators

  • Ben Gys, md · AZ Sint Dimpna, Geel

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2016-02-29
Completion
2016-02-29

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02813382 on ClinicalTrials.gov